Martínez de Lizarrondo, Sara <br/><br/>
Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  Jun 2012 
 - 1477-87 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4636 
<br/><br/><label>Standard No.: </label>10.1161/ATVBAHA.112.248773  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>Antibodies--pharmacology<br/>Blood Coagulation<br/>CD40 Antigens--antagonists & inhibitors<br/>CD40 Ligand--antagonists & inhibitors<br/>Case-Control Studies<br/>Cell-Derived Microparticles--enzymology<br/>Cells, Cultured<br/>Disease Models, Animal<br/>Disseminated Intravascular Coagulation--enzymology<br/>Endothelial Cells--drug effects<br/>Endotoxemia--enzymology<br/>Female<br/>Gene Expression Regulation, Enzymologic<br/>Hirudins--pharmacology<br/>Human Umbilical Vein Endothelial Cells--enzymology<br/>Humans<br/>Lipopolysaccharides--pharmacology<br/>Male<br/>Matrix Metalloproteinase 10--blood<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Middle Aged<br/>Mitogen-Activated Protein Kinase 8--antagonists & inhibitors<br/>Multivariate Analysis<br/>Peptides--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>RNA, Messenger--metabolism<br/>Receptor, PAR-1--agonists<br/>Risk Assessment<br/>Risk Factors<br/>Sepsis--enzymology<br/>Signal Transduction<br/>Spain<br/>Survival Analysis<br/>Thrombin--metabolism<br/>Time Factors<br/>Up-Regulation<br/>p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors<br/>Platelet Aggregation Inhibitors